Summary
Chey Yoon-chung, Vice President and Head of Business Development at SK Biopharmaceuticals, is the eldest daughter of SK Group Chairman Chey Tae-won and Roh Soh-yeong, director of Art Center Nabi. Born in 1989, Vice President Chey was promoted to the youngest executive in SK Group at the end of last year, seven years after joining SK Biopharmaceuticals. She majored in biology at the University of Chicago in the United States and worked as a consultant at Bain & Company, among other roles. In 2017, she joined SK Biopharmaceuticals as a senior manager (equivalent to a deputy position) in the Strategic Planning Team of the Business Strategy Office. She took a leave of absence in 2019 to pursue a master’s degree in bioinformatics at Stanford University in the U.S.
Chey returned to work in July 2021 and was promoted in January the following year to team leader in the Strategic Investment Team of the Global Investment Division, becoming a Head of the Division in just one year. She is recognized for her achievements in areas such as acquiring SK Life Science Labs, new investments, and business development. Her spouse, a former colleague from Bain & Company and a Seoul National University graduate, is known to be currently working in an IT venture company.
